GlaxoSmithKline Pharma

British biopharmaceutical group with its head office in London, formed in 2000 by the merger of Glaxo Wellcome and SmithKline Beecham and listed in London and New York, working in about seventy-five countries. Develops, makes and sells vaccines, specialty medicines and general medicines, with a portfolio covering respiratory and immunology, HIV through its ViiV Healthcare business, oncology and infectious disease, runs its own research centres and manufacturing sites worldwide, and operates global regulatory affairs, clinical development and pharmacovigilance.